| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.763 | 0.009 | 0.763 | Cyclophilin D inhibitor | 0.594 0.028 CID_124202069 | ||
| 0.756 | 0.002 | 0.756 | Glutamate decarboxylase inhibitor | |||
| 0.733 | 0.006 | 0.733 | Aldehyde oxidase inhibitor | |||
| 0.687 | 0.005 | 0.687 | Hypoglycemic | 0.621 0.007 CID_124202069 | ||
| 0.681 | 0.009 | 0.681 | Cholesterol antagonist | 0.613 0.017 CID_124202069 | ||
| 0.67 | 0.027 | 0.67 | Caspase 9 stimulant | 0.486 0.065 CID_124202069 | ||
| 0.635 | 0.012 | 0.635 | Vasodilator, peripheral | 0.399 0.055 CID_124202069 | ||
| 0.619 | 0.002 | 0.619 | Prostaglandin EP2 antagonist | 0.335 0.004 CID_124202069 | ||
| 0.615 | 0.004 | 0.615 | Peroxidase inhibitor | |||
| 0.615 | 0.015 | 0.615 | Antithrombotic | 0.6 0.016 CID_124202069 | ||
| 0.565 | 0.008 | 0.565 | Hypolipemic | 0.423 0.021 CID_124202069 | ||
| 0.582 | 0.033 | 0.582 | Transcription factor NF kappa B inhibitor | 0.562 0.036 CID_124202069 | ||
| 0.552 | 0.016 | 0.552 | Histamine release inhibitor | |||
| 0.536 | 0.003 | 0.536 | Electron transport complex I inhibitor | 0.178 0.011 CID_124202069 | ||
| 0.534 | 0.011 | 0.534 | Platelet antagonist | 0.282 0.059 CID_124202069 | ||
| 0.538 | 0.016 | 0.643 | Antioxidant | 0.643 0.009 CID_124202069 | CID_124202069 | |
| 0.525 | 0.017 | 0.525 | Apoptosis antagonist | 0.505 0.02 CID_124202069 | ||
| 0.5 | 0.004 | 0.5 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.5 | 0.004 | 0.5 | GABA C receptor agonist | |||
| 0.517 | 0.027 | 0.517 | 5 Hydroxytryptamine release inhibitor | |||
| 0.489 | 0.003 | 0.489 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.468 | 0.004 | 0.468 | Alcohol oxidase inhibitor | |||
| 0.47 | 0.006 | 0.47 | Alpha-N-acetylglucosaminidase inhibitor | 0.205 0.033 CID_124202069 | ||
| 0.467 | 0.013 | 0.495 | Interleukin 2 agonist | 0.495 0.009 CID_124202069 | CID_124202069 | |
| 0.468 | 0.02 | 0.493 | Vasodilator, coronary | 0.493 0.016 CID_124202069 | CID_124202069 | |
| 0.476 | 0.031 | 0.476 | 5 Hydroxytryptamine release stimulant | 0.218 0.107 CID_124202069 | ||
| 0.456 | 0.012 | 0.456 | Interleukin agonist | 0.362 0.026 CID_124202069 | ||
| 0.52 | 0.08 | 0.619 | Antiinflammatory | 0.619 0.048 CID_124202069 | CID_124202069 | |
| 0.458 | 0.021 | 0.467 | Free radical scavenger | 0.467 0.019 CID_124202069 | CID_124202069 | |
| 0.456 | 0.024 | 0.456 | Interleukin antagonist | |||
| 0.439 | 0.008 | 0.439 | Phospholipase C inhibitor | 0.153 0.1 CID_124202069 | ||
| 0.438 | 0.009 | 0.438 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.459 | 0.044 | 0.48 | Immunosuppressant | 0.48 0.038 CID_124202069 | CID_124202069 | |
| 0.421 | 0.009 | 0.421 | Bone formation stimulant | |||
| 0.441 | 0.032 | 0.441 | Spasmolytic | 0.275 0.081 CID_124202069 | ||
| 0.411 | 0.006 | 0.411 | Insulin sensitizer | 0.23 0.047 CID_124202069 | ||
| 0.41 | 0.006 | 0.41 | Insulin secretagoues | 0.217 0.028 CID_124202069 | ||
| 0.413 | 0.011 | 0.496 | Melanin inhibitor | 0.496 0.007 CID_124202069 | CID_124202069 | |
| 0.421 | 0.02 | 0.448 | Vasodilator | 0.448 0.016 CID_124202069 | CID_124202069 | |
| 0.41 | 0.014 | 0.41 | Sodium/bile acid cotransporter inhibitor | 0.197 0.192 CID_124202069 | ||
| 0.436 | 0.04 | 0.536 | Immunostimulant | 0.536 0.024 CID_124202069 | CID_124202069 | |
| 0.394 | 0.004 | 0.394 | Succinate dehydrogenase inhibitor | |||
| 0.397 | 0.012 | 0.419 | Monophenol monooxygenase inhibitor | 0.419 0.01 CID_124202069 | CID_124202069 | |
| 0.393 | 0.01 | 0.393 | Amylase inhibitor | 0.381 0.01 CID_124202069 | ||
| 0.382 | 0.004 | 0.382 | Histidine decarboxylase inhibitor | |||
| 0.38 | 0.004 | 0.38 | Prostaglandin antagonist | |||
| 0.379 | 0.004 | 0.379 | TRPA1 agonist | |||
| 0.378 | 0.006 | 0.378 | Aldehyde dehydrogenase inhibitor | |||
| 0.391 | 0.019 | 0.391 | Platelet aggregation inhibitor | |||
| 0.372 | 0.002 | 0.372 | Fumarate hydratase inhibitor | |||
| 0.43 | 0.064 | 0.596 | Antibacterial | 0.596 0.02 CID_124202069 | CID_124202069 | |
| 0.381 | 0.019 | 0.381 | Growth hormone agonist | |||
| 0.365 | 0.004 | 0.365 | Triose-phosphate isomerase inhibitor | 0.156 0.018 CID_124202069 | ||
| 0.367 | 0.01 | 0.443 | Protein kinase stimulant | 0.443 0.006 CID_124202069 | CID_124202069 | |
| 0.385 | 0.029 | 0.385 | Superoxide dismutase inhibitor | |||
| 0.398 | 0.045 | 0.398 | Caspase 3 stimulant | 0.391 0.047 CID_124202069 | ||
| 0.361 | 0.013 | 0.361 | Interferon gamma antagonist | 0.303 0.019 CID_124202069 | ||
| 0.372 | 0.03 | 0.372 | Amyloid beta aggregation inhibitor | 0.196 0.08 CID_124202069 | ||
| 0.375 | 0.034 | 0.375 | Antiamyloidogenic | 0.168 0.125 CID_124202069 | ||
| 0.366 | 0.029 | 0.366 | Insulysin inhibitor | |||
| 0.34 | 0.004 | 0.34 | Peroxisome proliferator-activated receptor gamma agonist | 0.078 0.042 CID_124202069 | ||
| 0.339 | 0.007 | 0.339 | Cystathionine beta-synthase inhibitor | |||
| 0.336 | 0.008 | 0.336 | Cholesterol synthesis inhibitor | 0.099 0.089 CID_124202069 | ||
| 0.35 | 0.024 | 0.444 | Anesthetic general | 0.444 0.012 CID_124202069 | CID_124202069 | |
| 0.33 | 0.004 | 0.33 | Prostaglandin E2 antagonist | |||
| 0.319 | 0.005 | 0.319 | Phosphofructokinase-1 inhibitor | 0.201 0.011 CID_124202069 | ||
| 0.324 | 0.013 | 0.324 | Neurotrophic factor enhancer | 0.247 0.04 CID_124202069 | ||
| 0.328 | 0.018 | 0.328 | DNA methyltransferase I inhibitor | |||
| 0.312 | 0.002 | 0.312 | Prostaglandin agonist | |||
| 0.379 | 0.071 | 0.379 | GABA C receptor rho-3 antagonist | |||
| 0.342 | 0.035 | 0.44 | Angiogenesis stimulant | 0.44 0.016 CID_124202069 | CID_124202069 | |
| 0.308 | 0.004 | 0.308 | Leukotriene antagonist | |||
| 0.311 | 0.008 | 0.311 | Expectorant | 0.216 0.017 CID_124202069 | ||
| 0.318 | 0.016 | 0.318 | Protein-tyrosine phosphatase inhibitor | 0.17 0.062 CID_124202069 | ||
| 0.323 | 0.022 | 0.323 | DNA methylase inhibitor | |||
| 0.313 | 0.012 | 0.313 | Phospholipase A2 inhibitor | 0.179 0.054 CID_124202069 | ||
| 0.306 | 0.005 | 0.306 | Catenin beta inhibitor | |||
| 0.305 | 0.006 | 0.305 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.086 0.071 CID_124202069 | ||
| 0.302 | 0.005 | 0.302 | Porphobilinogen synthase inhibitor | |||
| 0.328 | 0.032 | 0.328 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.3 | 0.005 | 0.3 | Toll-Like receptor 2 antagonist | 0.103 0.099 CID_124202069 | ||
| 0.3 | 0.005 | 0.3 | Glutamate dehydrogenase inhibitor | |||
| 0.313 | 0.022 | 0.313 | Thrombolytic | 0.241 0.036 CID_124202069 | ||
| 0.327 | 0.036 | 0.358 | DNA synthesis inhibitor | 0.358 0.029 CID_124202069 | CID_124202069 | |
| 0.332 | 0.043 | 0.465 | Tumour necrosis factor alpha release inhibitor | 0.465 0.018 CID_124202069 | CID_124202069 | |
| 0.4 | 0.113 | 0.595 | Apoptosis agonist | 0.595 0.05 CID_124202069 | CID_124202069 | |
| 0.38 | 0.095 | 0.38 | Calcium channel L-type activator | |||
| 0.322 | 0.037 | 0.322 | Psychostimulant | |||
| 0.343 | 0.062 | 0.343 | Immunomodulator | 0.241 0.122 CID_124202069 | ||
| 0.305 | 0.028 | 0.386 | Hepatoprotectant | 0.386 0.014 CID_124202069 | CID_124202069 | |
| 0.279 | 0.005 | 0.279 | Vanilloid agonist | 0.124 0.017 CID_124202069 | ||
| 0.303 | 0.031 | 0.303 | Gastrin inhibitor | |||
| 0.297 | 0.025 | 0.297 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.159 0.129 CID_124202069 | ||
| 0.276 | 0.008 | 0.276 | Adenylate kinase inhibitor | |||
| 0.348 | 0.083 | 0.348 | Toll-Like receptor agonist | |||
| 0.268 | 0.005 | 0.268 | Mucolytic | 0.138 0.04 CID_124202069 | ||
| 0.266 | 0.003 | 0.266 | Prostaglandin EP3 antagonist | |||
| 0.265 | 0.002 | 0.265 | Prostaglandin E2 agonist | |||
| 0.264 | 0.004 | 0.264 | Adenylate cyclase stimulant | 0.165 0.041 CID_124202069 | ||
| 0.259 | 0.002 | 0.259 | ATP citrate lysase inhibitor | |||
| 0.269 | 0.014 | 0.269 | Protein-tyrosine phosphatase 1B inhibitor | 0.096 0.082 CID_124202069 | ||
| 0.278 | 0.022 | 0.371 | Lipid peroxidase inhibitor | 0.371 0.011 CID_124202069 | CID_124202069 | |
| 0.26 | 0.005 | 0.26 | Vanilloid 1 agonist | 0.194 0.014 CID_124202069 | ||
| 0.27 | 0.021 | 0.27 | Nitric-oxide synthase stimulant | 0.234 0.045 CID_124202069 | ||
| 0.29 | 0.042 | 0.411 | Nitric oxide antagonist | 0.411 0.024 CID_124202069 | CID_124202069 | |
| 0.313 | 0.065 | 0.313 | Lipoxygenase inhibitor | |||
| 0.279 | 0.033 | 0.279 | Non-steroidal antiinflammatory agent | 0.163 0.101 CID_124202069 | ||
| 0.254 | 0.013 | 0.254 | Ferrochelatase inhibitor | |||
| 0.25 | 0.009 | 0.25 | Catalase inhibitor | |||
| 0.246 | 0.005 | 0.246 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.248 | 0.008 | 0.248 | Alcohol dehydrogenase inhibitor | |||
| 0.251 | 0.013 | 0.251 | Interleukin 4 antagonist | 0.167 0.037 CID_124202069 | ||
| 0.245 | 0.009 | 0.245 | Carbonic anhydrase XIII inhibitor | 0.067 0.061 CID_124202069 | ||
| 0.232 | 0.004 | 0.232 | DOPA decarboxylase inhibitor | |||
| 0.229 | 0.003 | 0.229 | Aconitate hydratase inhibitor | |||
| 0.228 | 0.005 | 0.228 | Prolactin inhibitor | |||
| 0.243 | 0.02 | 0.243 | Adenylate cyclase inhibitor | |||
| 0.32 | 0.098 | 0.32 | Toll-Like receptor 7 agonist | |||
| 0.239 | 0.017 | 0.239 | ATPase inhibitor | 0.226 0.021 CID_124202069 | ||
| 0.232 | 0.011 | 0.232 | Carbonic anhydrase III inhibitor | |||
| 0.221 | 0.003 | 0.221 | GABA B receptor agonist | |||
| 0.219 | 0.003 | 0.219 | Prostaglandin EP4 antagonist | |||
| 0.219 | 0.003 | 0.219 | Leukotriene B4 antagonist | 0.057 0.032 CID_124202069 | ||
| 0.222 | 0.009 | 0.222 | Photosensitizer | 0.131 0.045 CID_124202069 | ||
| 0.228 | 0.021 | 0.228 | DNA polymerase I inhibitor | 0.189 0.032 CID_124202069 | ||
| 0.234 | 0.027 | 0.234 | Interleukin 6 antagonist | 0.18 0.055 CID_124202069 | ||
| 0.221 | 0.016 | 0.221 | Arachidonic acid antagonist | |||
| 0.222 | 0.017 | 0.222 | Aminopeptidase B inhibitor | |||
| 0.222 | 0.019 | 0.222 | Neurotrophic factor | 0.114 0.106 CID_124202069 | ||
| 0.245 | 0.043 | 0.245 | P-glycoprotein inhibitor | 0.203 0.062 CID_124202069 | ||
| 0.209 | 0.008 | 0.209 | Keratolytic | |||
| 0.199 | 0.004 | 0.199 | GABA aminotransferase inhibitor | 0.089 0.036 CID_124202069 | ||
| 0.199 | 0.011 | 0.199 | Creatine kinase inhibitor | |||
| 0.195 | 0.007 | 0.195 | Aminopeptidase I inhibitor | |||
| 0.205 | 0.023 | 0.205 | Cell adhesion inhibitor | 0.149 0.047 CID_124202069 | ||
| 0.199 | 0.019 | 0.238 | Cyclooxygenase 3 inhibitor | 0.238 0.01 CID_124202069 | CID_124202069 | |
| 0.184 | 0.004 | 0.184 | Prostaglandin F2 alpha antagonist | 0.063 0.042 CID_124202069 | ||
| 0.215 | 0.039 | 0.215 | Diuretic | |||
| 0.18 | 0.007 | 0.18 | Biliverdin reductase inhibitor | |||
| 0.235 | 0.062 | 0.312 | Peptidyltransferase inhibitor | 0.312 0.021 CID_124202069 | CID_124202069 | |
| 0.218 | 0.046 | 0.218 | Lipocortins synthesis antagonist | |||
| 0.171 | 0.002 | 0.171 | Prostaglandin EP4 agonist | |||
| 0.175 | 0.011 | 0.186 | Toll-Like receptor 4 antagonist | 0.186 0.009 CID_124202069 | CID_124202069 | |
| 0.229 | 0.065 | 0.229 | RNA-directed DNA polymerase inhibitor | 0.202 0.096 CID_124202069 | ||
| 0.192 | 0.029 | 0.206 | Alkylator | 0.206 0.025 CID_124202069 | CID_124202069 | |
| 0.17 | 0.01 | 0.17 | Anabolic | |||
| 0.276 | 0.117 | 0.276 | Calcium channel activator | |||
| 0.171 | 0.016 | 0.171 | Folate antagonist | |||
| 0.16 | 0.005 | 0.16 | Plasminogen activator inhibitor antagonist | |||
| 0.168 | 0.015 | 0.168 | Ca2+-transporting ATPase inhibitor | 0.132 0.109 CID_124202069 | ||
| 0.172 | 0.02 | 0.172 | GABA C receptor antagonist | |||
| 0.178 | 0.026 | 0.226 | Microtubule formation inhibitor | 0.226 0.014 CID_124202069 | CID_124202069 | |
| 0.176 | 0.025 | 0.176 | Xanthine oxidase inhibitor | 0.143 0.037 CID_124202069 | ||
| 0.188 | 0.038 | 0.188 | Hemostatic | |||
| 0.169 | 0.019 | 0.169 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.167 | 0.018 | 0.167 | Carbonic anhydrase VI inhibitor | |||
| 0.19 | 0.041 | 0.19 | Neurotensin receptor agonist | |||
| 0.167 | 0.019 | 0.167 | AMP-activated protein kinase stimulant | 0.161 0.022 CID_124202069 | ||
| 0.171 | 0.023 | 0.171 | UDP-glucose 4-epimerase inhibitor | 0.158 0.026 CID_124202069 | ||
| 0.177 | 0.031 | 0.177 | Farnesoid X receptor antagonist | |||
| 0.169 | 0.022 | 0.169 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.191 | 0.045 | 0.199 | NOS3 expression enhancer | 0.199 0.041 CID_124202069 | CID_124202069 | |
| 0.188 | 0.043 | 0.188 | Hexokinase inhibitor | |||
| 0.162 | 0.017 | 0.162 | GABA C receptor rho-1 antagonist | |||
| 0.209 | 0.066 | 0.209 | Platelet adhesion inhibitor | 0.166 0.091 CID_124202069 | ||
| 0.141 | 0.002 | 0.141 | Prostaglandin EP2 agonist | |||
| 0.155 | 0.016 | 0.155 | NADH dehydrogenase inhibitor | 0.137 0.021 CID_124202069 | ||
| 0.161 | 0.024 | 0.161 | Mediator release inhibitor | 0.135 0.036 CID_124202069 | ||
| 0.154 | 0.018 | 0.154 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.177 | 0.042 | 0.236 | Cell wall synthesis inhibitor | 0.236 0.019 CID_124202069 | CID_124202069 | |
| 0.154 | 0.018 | 0.154 | Electrolyte absorption antagonist | |||
| 0.138 | 0.003 | 0.138 | Glucose-6-phosphate isomerase inhibitor | 0.096 0.005 CID_124202069 | ||
| 0.228 | 0.094 | 0.295 | DNA damaging | 0.295 0.059 CID_124202069 | CID_124202069 | |
| 0.145 | 0.014 | 0.145 | Interleukin 12 antagonist | 0.092 0.067 CID_124202069 | ||
| 0.19 | 0.061 | 0.19 | Mcl-1 antagonist | |||
| 0.141 | 0.014 | 0.141 | Ornithine decarboxylase inhibitor | |||
| 0.132 | 0.006 | 0.132 | Estrogen-related receptor beta agonist | |||
| 0.241 | 0.114 | 0.241 | 12-Lipoxygenase inhibitor | |||
| 0.133 | 0.008 | 0.133 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.135 | 0.011 | 0.135 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.135 | 0.011 | 0.135 | Bile acid receptor antagonist | |||
| 0.135 | 0.013 | 0.135 | Interferon agonist | 0.09 0.038 CID_124202069 | ||
| 0.126 | 0.005 | 0.126 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.153 | 0.032 | 0.153 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.226 | 0.105 | 0.226 | Transcription factor STAT3 inhibitor | |||
| 0.159 | 0.04 | 0.159 | Cathepsin H inhibitor | |||
| 0.155 | 0.036 | 0.155 | Heat shock protein 70 antagonist | |||
| 0.127 | 0.009 | 0.127 | Estrogen receptor beta agonist | |||
| 0.128 | 0.01 | 0.128 | Glycine receptor agonist | |||
| 0.134 | 0.018 | 0.134 | Carbonic anhydrase V inhibitor | |||
| 0.124 | 0.011 | 0.124 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.127 | 0.014 | 0.127 | Leukotriene synthesis inhibitor | |||
| 0.119 | 0.007 | 0.119 | Estrogen receptor alpha agonist | |||
| 0.127 | 0.016 | 0.127 | Carbonic anhydrase VA inhibitor | |||
| 0.116 | 0.005 | 0.116 | Sphingosine kinase inhibitor | |||
| 0.147 | 0.036 | 0.147 | Chelator | |||
| 0.139 | 0.029 | 0.139 | Estrogen antagonist | |||
| 0.121 | 0.012 | 0.121 | Carbonic anhydrase VB inhibitor | |||
| 0.13 | 0.022 | 0.13 | Macrophage migration inhibitory factor inhibitor | |||
| 0.112 | 0.004 | 0.112 | Leukotriene C antagonist | |||
| 0.126 | 0.018 | 0.126 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.121 | 0.014 | 0.121 | Estrogen agonist | |||
| 0.141 | 0.034 | 0.141 | Protease inhibitor | |||
| 0.128 | 0.022 | 0.128 | Adrenaline agonist | |||
| 0.161 | 0.055 | 0.161 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.156 | 0.052 | 0.156 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.125 | 0.021 | 0.308 | Selectin antagonist | 0.308 0.005 CID_124202069 | CID_124202069 | |
| 0.12 | 0.017 | 0.12 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.105 | 0.003 | 0.105 | Prostacyclin agonist | 0.02 0.008 CID_124202069 | ||
| 0.113 | 0.013 | 0.113 | Purinergic P2X1 antagonist | |||
| 0.141 | 0.041 | 0.141 | 5-Lipoxygenase inhibitor | |||
| 0.126 | 0.026 | 0.126 | Estrogen receptor beta antagonist | |||
| 0.224 | 0.125 | 0.224 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.114 | 0.015 | 0.114 | Aldose reductase inhibitor | 0.056 0.034 CID_124202069 | ||
| 0.125 | 0.026 | 0.125 | Cathepsin G inhibitor | |||
| 0.125 | 0.027 | 0.125 | ABCA1 expression enhancer | |||
| 0.114 | 0.016 | 0.114 | Argininosuccinate synthase inhibitor | |||
| 0.112 | 0.014 | 0.235 | Neuraminidase (influenza) inhibitor | 0.235 0.004 CID_124202069 | CID_124202069 | |
| 0.115 | 0.018 | 0.115 | HIV-1 integrase (Strand Transfer) inhibitor | 0.053 0.047 CID_124202069 | ||
| 0.098 | 0.001 | 0.098 | Thromboxane agonist | |||
| 0.105 | 0.009 | 0.105 | Thromboxane antagonist | |||
| 0.107 | 0.012 | 0.107 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.115 | 0.021 | 0.115 | CDC25A inhibitor | |||
| 0.146 | 0.052 | 0.159 | Topoisomerase II inhibitor | 0.159 0.045 CID_124202069 | CID_124202069 | |
| 0.103 | 0.009 | 0.103 | CD45 antagonist | |||
| 0.096 | 0.004 | 0.096 | Leukotriene B4 receptor 1 antagonist | |||
| 0.106 | 0.014 | 0.106 | Beta adrenoreceptor antagonist | |||
| 0.157 | 0.065 | 0.157 | CF transmembrane conductance regulator agonist | |||
| 0.095 | 0.005 | 0.095 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.103 | 0.014 | 0.241 | Neuraminidase inhibitor | 0.241 0.004 CID_124202069 | CID_124202069 | |
| 0.099 | 0.011 | 0.099 | Carbonic anhydrase XIV inhibitor | 0.045 0.039 CID_124202069 | ||
| 0.203 | 0.116 | 0.203 | Cardiotonic | |||
| 0.132 | 0.044 | 0.132 | Caspase 3 inhibitor | |||
| 0.089 | 0.002 | 0.089 | Prostaglandin F2 alpha agonist | 0.021 0.019 CID_124202069 | ||
| 0.095 | 0.009 | 0.095 | Thromboxane A2 antagonist | |||
| 0.109 | 0.024 | 0.127 | Na+ K+ transporting ATPase inhibitor | 0.127 0.013 CID_124202069 | CID_124202069 | |
| 0.089 | 0.005 | 0.089 | Prostacyclin antagonist | |||
| 0.119 | 0.036 | 0.119 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.101 | 0.019 | 0.101 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.122 | 0.04 | 0.122 | Sphingomyelinase inhibitor | |||
| 0.11 | 0.028 | 0.11 | ATPase (Vacuolar H+) inhibitor | 0.109 0.029 CID_124202069 | ||
| 0.094 | 0.013 | 0.094 | Glutamate (mGluR6) antagonist | |||
| 0.101 | 0.02 | 0.101 | Ribonucleotide reductase inhibitor | |||
| 0.119 | 0.039 | 0.242 | Antineoplastic antibiotic | 0.242 0.015 CID_124202069 | CID_124202069 | |
| 0.134 | 0.056 | 0.134 | Proteasome inhibitor | |||
| 0.083 | 0.005 | 0.083 | HIV-1 protease inhibitor | 0.043 0.029 CID_124202069 | ||
| 0.085 | 0.008 | 0.161 | Mannosidase inhibitor | 0.161 0.004 CID_124202069 | CID_124202069 | |
| 0.107 | 0.03 | 0.107 | Cell adhesion molecule inhibitor | |||
| 0.206 | 0.13 | 0.206 | Transcription factor STAT inhibitor | |||
| 0.111 | 0.037 | 0.111 | Thioredoxin inhibitor | 0.09 0.062 CID_124202069 | ||
| 0.088 | 0.014 | 0.088 | Beta 1 adrenoreceptor antagonist | |||
| 0.083 | 0.01 | 0.083 | Thromboxane synthase inhibitor | |||
| 0.172 | 0.099 | 0.172 | Pyruvate kinase inhibitor | |||
| 0.158 | 0.086 | 0.158 | Dual specificity phosphatase inhibitor | |||
| 0.126 | 0.054 | 0.126 | Interleukin 8 antagonist | |||
| 0.082 | 0.011 | 0.082 | Beta 2 adrenoreceptor antagonist | |||
| 0.148 | 0.076 | 0.148 | GABA C receptor rho-2 antagonist | |||
| 0.082 | 0.012 | 0.082 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.108 | 0.039 | 0.108 | Phosphodiesterase 6D inhibitor | 0.094 0.065 CID_124202069 | ||
| 0.075 | 0.008 | 0.075 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.108 | 0.042 | 0.108 | NMDA receptor antagonist | |||
| 0.101 | 0.036 | 0.101 | Glutathione S-transferase inhibitor | |||
| 0.08 | 0.015 | 0.08 | Sphingosine kinase 2 inhibitor | |||
| 0.07 | 0.004 | 0.07 | Leukotriene C4 antagonist | |||
| 0.069 | 0.004 | 0.069 | Prostaglandin D2 agonist | |||
| 0.084 | 0.019 | 0.104 | Nitric oxide donor | 0.104 0.007 CID_124202069 | CID_124202069 | |
| 0.082 | 0.017 | 0.082 | Bombesin 2 receptor antagonist | |||
| 0.085 | 0.02 | 0.085 | Beta 3 adrenoreceptor antagonist | |||
| 0.072 | 0.007 | 0.072 | Arginase inhibitor | |||
| 0.074 | 0.011 | 0.074 | Adenosine deaminase inhibitor | |||
| 0.069 | 0.009 | 0.069 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.09 | 0.031 | 0.09 | HIV-1 integrase inhibitor | |||
| 0.064 | 0.006 | 0.064 | Glutamate (mGluR8) agonist | |||
| 0.144 | 0.086 | 0.144 | Anticoagulant | 0.117 0.116 CID_124202069 | ||
| 0.1 | 0.043 | 0.1 | Glutamate release inhibitor | |||
| 0.11 | 0.053 | 0.11 | Gastric antisecretory | |||
| 0.087 | 0.03 | 0.087 | Glucagon-like peptide 1 agonist | |||
| 0.096 | 0.04 | 0.096 | Hematopoietic | |||
| 0.072 | 0.016 | 0.072 | Beta 2 adrenoreceptor agonist | |||
| 0.068 | 0.012 | 0.068 | Sphingosine 1-phosphate receptor agonist | |||
| 0.061 | 0.006 | 0.061 | Lysine carboxypeptidase inhibitor | |||
| 0.07 | 0.017 | 0.107 | Alpha-mannosidase inhibitor | 0.107 0.005 CID_124202069 | CID_124202069 | |
| 0.058 | 0.005 | 0.058 | HMG CoA reductase inhibitor | 0.038 0.018 CID_124202069 | ||
| 0.064 | 0.01 | 0.064 | Dopamine D5 agonist | |||
| 0.077 | 0.024 | 0.077 | MDM2 inhibitor | |||
| 0.069 | 0.016 | 0.07 | Adenine nucleotide translocase inhibitor | 0.07 0.015 CID_124202069 | CID_124202069 | |
| 0.058 | 0.007 | 0.058 | Heme oxygenase inhibitor | |||
| 0.069 | 0.018 | 0.069 | Toll-Like receptor 2 agonist | |||
| 0.063 | 0.012 | 0.063 | AICAR transformylase inhibitor | |||
| 0.061 | 0.011 | 0.061 | Phosphoglycerate kinase inhibitor | |||
| 0.095 | 0.044 | 0.138 | Transcription factor NF kappa B stimulant | 0.138 0.019 CID_124202069 | CID_124202069 | |
| 0.074 | 0.024 | 0.074 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.074 | 0.024 | 0.074 | Ornithine carbamoyltransferase inhibitor | |||
| 0.136 | 0.086 | 0.136 | Thiol protease inhibitor | |||
| 0.111 | 0.061 | 0.111 | Nav1.4 sodium channel blocker | |||
| 0.058 | 0.009 | 0.058 | Leukotriene D4 antagonist | |||
| 0.106 | 0.057 | 0.106 | Bronchodilator | |||
| 0.076 | 0.027 | 0.076 | Interferon inducer | |||
| 0.065 | 0.016 | 0.065 | Macrophage elastase inhibitor | |||
| 0.084 | 0.035 | 0.084 | Vanilloid 4 agonist | |||
| 0.147 | 0.099 | 0.147 | Dual specificity phosphatase 3 inhibitor | |||
| 0.1 | 0.053 | 0.1 | Uric acid excretion stimulant | |||
| 0.057 | 0.01 | 0.057 | Beta adrenoreceptor agonist | |||
| 0.055 | 0.01 | 0.055 | Glutamate (mGluR3) antagonist | |||
| 0.049 | 0.004 | 0.049 | Leukotriene B4 receptor 2 antagonist | |||
| 0.056 | 0.012 | 0.056 | DNA gyrase subunit A inhibitor | |||
| 0.047 | 0.005 | 0.047 | Thyroid hormone agonist | |||
| 0.066 | 0.024 | 0.066 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.104 | 0.062 | 0.104 | Carbonic anhydrase XV inhibitor | |||
| 0.047 | 0.005 | 0.047 | Glutamate (mGluR3) agonist | |||
| 0.073 | 0.034 | 0.073 | NMDA receptor agonist | |||
| 0.056 | 0.016 | 0.149 | Neuraminidase (Influenza A) inhibitor | 0.149 0.003 CID_124202069 | CID_124202069 | |
| 0.087 | 0.048 | 0.089 | Topoisomerase II alpha inhibitor | 0.089 0.047 CID_124202069 | CID_124202069 | |
| 0.063 | 0.025 | 0.063 | Pregnane X receptor antagonist | |||
| 0.083 | 0.045 | 0.083 | Estrogen receptor alpha antagonist | |||
| 0.07 | 0.032 | 0.07 | Caspase 9 inhibitor | |||
| 0.052 | 0.014 | 0.052 | Squalene synthetase inhibitor | |||
| 0.087 | 0.05 | 0.087 | D-Ala-D-Ala ligase inhibitor | |||
| 0.051 | 0.014 | 0.051 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.116 | 0.08 | 0.116 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.045 | 0.009 | 0.045 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.08 | 0.043 | 0.08 | Lipase inhibitor | |||
| 0.05 | 0.014 | 0.05 | Kainate receptor agonist | |||
| 0.039 | 0.003 | 0.039 | Thromboxane A2 agonist | |||
| 0.097 | 0.061 | 0.097 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.061 | 0.026 | 0.061 | DNA helicase inhibitor | |||
| 0.051 | 0.016 | 0.051 | Sphingosine kinase 1 inhibitor | |||
| 0.039 | 0.004 | 0.039 | G-protein-coupled receptor 120 agonist | |||
| 0.058 | 0.024 | 0.058 | Topoisomerase II beta inhibitor | |||
| 0.065 | 0.031 | 0.065 | Maillard reaction inhibitor | |||
| 0.118 | 0.085 | 0.118 | Antibacterial (Helicobacter pylori) | |||
| 0.049 | 0.016 | 0.049 | GABA uptake inhibitor | |||
| 0.089 | 0.057 | 0.089 | Interleukin 5 antagonist | |||
| 0.038 | 0.006 | 0.038 | Prostaglandin H2 antagonist | |||
| 0.049 | 0.017 | 0.049 | Calcitonin receptor agonist | |||
| 0.055 | 0.023 | 0.055 | Carbonic anhydrase VII inhibitor | |||
| 0.06 | 0.03 | 0.06 | Angiotensin-converting enzyme inhibitor | |||
| 0.042 | 0.011 | 0.042 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.057 | 0.027 | 0.057 | Vanilloid 2 antagonist | |||
| 0.047 | 0.018 | 0.047 | Membrane dipeptidase inhibitor | |||
| 0.043 | 0.014 | 0.043 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.092 | 0.063 | 0.092 | Potassium channel (Ca-activated) activator | |||
| 0.042 | 0.014 | 0.042 | Glutamate (mGluR8) antagonist | |||
| 0.034 | 0.006 | 0.034 | Vanilloid 2 agonist | 0.028 0.013 CID_124202069 | ||
| 0.055 | 0.028 | 0.055 | Antimetabolite | |||
| 0.061 | 0.035 | 0.061 | Ryanodine receptor antagonist | |||
| 0.067 | 0.041 | 0.067 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.078 | 0.052 | 0.078 | MAP kinase kinase 7 inhibitor | |||
| 0.045 | 0.02 | 0.045 | Retinoid X receptor agonist | |||
| 0.069 | 0.044 | 0.069 | Glutamate (mGluR7) antagonist | |||
| 0.05 | 0.025 | 0.05 | Carbonic anhydrase IV inhibitor | |||
| 0.038 | 0.013 | 0.038 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.039 | 0.017 | 0.039 | Free fatty acid receptor 1 antagonist | |||
| 0.078 | 0.055 | 0.078 | Metalloproteinase-2 inhibitor | |||
| 0.032 | 0.009 | 0.032 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.042 | 0.019 | 0.042 | VCAM-1 antagonist | |||
| 0.042 | 0.02 | 0.042 | VCAM antagonist | |||
| 0.029 | 0.007 | 0.029 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.055 | 0.033 | 0.055 | Heparanase inhibitor | |||
| 0.028 | 0.007 | 0.028 | Free fatty acid receptor 1 agonist | |||
| 0.042 | 0.02 | 0.042 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.055 | 0.033 | 0.055 | NMDA 2A receptor antagonist | |||
| 0.078 | 0.057 | 0.078 | Chymotrypsin inhibitor | |||
| 0.044 | 0.024 | 0.044 | Thymidine kinase inhibitor | |||
| 0.027 | 0.006 | 0.027 | Neuraminidase (Influenza B) inhibitor | |||
| 0.056 | 0.037 | 0.056 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.023 | 0.005 | 0.023 | Vitamin D receptor agonist | |||
| 0.035 | 0.017 | 0.035 | Cholesterol ester transfer protein antagonist | |||
| 0.028 | 0.01 | 0.028 | Glutamate (mGluR1a) agonist | |||
| 0.03 | 0.012 | 0.034 | Toll-Like receptor 4 agonist | 0.034 0.008 CID_124202069 | CID_124202069 | |
| 0.058 | 0.041 | 0.058 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.033 | 0.016 | 0.033 | Uridine phosphorylase inhibitor | |||
| 0.044 | 0.027 | 0.044 | GABA B receptor antagonist | |||
| 0.049 | 0.033 | 0.049 | Dopamine beta hydroxylase inhibitor | |||
| 0.027 | 0.01 | 0.027 | Beta 1 adrenoreceptor agonist | |||
| 0.022 | 0.006 | 0.022 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.041 | 0.025 | 0.041 | Dihydropteroate synthase inhibitor | |||
| 0.211 | 0.196 | 0.211 | Antiobesity | |||
| 0.019 | 0.004 | 0.019 | Glutamate (mGluR6) agonist | |||
| 0.027 | 0.013 | 0.027 | Glutamate (mGluR1) agonist | |||
| 0.053 | 0.039 | 0.053 | Cathepsin D inhibitor | |||
| 0.074 | 0.06 | 0.074 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.021 | 0.008 | 0.021 | Ileal bile acid transport inhibitor | |||
| 0.024 | 0.012 | 0.024 | Prostaglandin EP1 antagonist | |||
| 0.022 | 0.009 | 0.022 | Aminopeptidase A inhibitor | |||
| 0.059 | 0.046 | 0.059 | NMDA 2C receptor antagonist | |||
| 0.066 | 0.054 | 0.066 | Exportin-1 inhibitor | |||
| 0.065 | 0.054 | 0.065 | Elastase 1 inhibitor | |||
| 0.093 | 0.082 | 0.093 | Beta glucuronidase inhibitor | |||
| 0.177 | 0.166 | 0.177 | Neuropeptide Y2 antagonist | |||
| 0.038 | 0.027 | 0.038 | NMDA receptor subunit 3A antagonist | |||
| 0.045 | 0.034 | 0.045 | Phosphorylase inhibitor | |||
| 0.061 | 0.05 | 0.061 | CDC25B inhibitor | |||
| 0.043 | 0.032 | 0.043 | NMDA receptor subunit 3B antagonist | |||
| 0.016 | 0.006 | 0.016 | Integrin beta6 antagonist | |||
| 0.022 | 0.011 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.071 | 0.061 | 0.071 | Analgesic, opioid | |||
| 0.056 | 0.046 | 0.056 | Carbonic anhydrase stimulant | |||
| 0.015 | 0.005 | 0.015 | Calcium-dependent phospholipase A2 inhibitor | |||
| 0.075 | 0.065 | 0.075 | Glycine receptor antagonist | |||
| 0.056 | 0.046 | 0.056 | Lipocortins synthesis agonist | 0.055 0.047 CID_124202069 | ||
| 0.018 | 0.008 | 0.018 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | |||
| 0.043 | 0.034 | 0.043 | Oleamide hydrolase inhibitor | |||
| 0.018 | 0.009 | 0.018 | Thyroid hormone alpha antagonist | |||
| 0.029 | 0.021 | 0.029 | Glucagon receptor antagonist | |||
| 0.018 | 0.009 | 0.018 | Thyroid hormone alpha agonist | |||
| 0.032 | 0.024 | 0.032 | Carboxypeptidase B inhibitor | |||
| 0.023 | 0.015 | 0.023 | Isoleucine-tRNA ligase inhibitor | |||
| 0.056 | 0.049 | 0.056 | TRPA1 antagonist | |||
| 0.026 | 0.019 | 0.026 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.049 | 0.041 | 0.109 | Protein 50S ribosomal subunit inhibitor | 0.109 0.011 CID_124202069 | CID_124202069 | |
| 0.034 | 0.027 | 0.034 | Renin inhibitor | |||
| 0.052 | 0.045 | 0.052 | Xanthine dehydrogenase inhibitor | |||
| 0.022 | 0.015 | 0.022 | Vitamin D receptor antagonist | |||
| 0.019 | 0.013 | 0.019 | Estrogen-related receptor gamma agonist | |||
| 0.017 | 0.011 | 0.017 | Carbonic anhydrase VIII inhibitor | |||
| 0.017 | 0.011 | 0.017 | Carbonic anhydrase X inhibitor | |||
| 0.016 | 0.01 | 0.016 | Calcium-sensing receptor antagonist | |||
| 0.078 | 0.072 | 0.078 | Opioid antagonist | |||
| 0.01 | 0.005 | 0.01 | Thyroid hormone beta agonist | |||
| 0.053 | 0.047 | 0.053 | Immunoglobulin Fc receptor antagonist | |||
| 0.028 | 0.023 | 0.028 | Plasmepsin I inhibitor | |||
| 0.07 | 0.065 | 0.07 | Somatostatin 1 agonist | |||
| 0.025 | 0.021 | 0.034 | Sodium/glucose cotransporter 2 inhibitor | 0.034 0.01 CID_124202069 | CID_124202069 | |
| 0.067 | 0.062 | 0.067 | Metalloproteinase-9 inhibitor | |||
| 0.093 | 0.088 | 0.093 | Factor V inhibitor | |||
| 0.13 | 0.127 | 0.13 | Tumour necrosis factor antagonist | |||
| 0.013 | 0.01 | 0.013 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.024 | 0.021 | 0.037 | Sodium/glucose cotransporter inhibitor | 0.037 0.008 CID_124202069 | CID_124202069 | |
| 0.018 | 0.016 | 0.018 | Antibiotic Anthracycline-like | |||
| 0.028 | 0.026 | 0.028 | Caspase 2 inhibitor | |||
| 0.03 | 0.028 | 0.03 | Catechol O-methyltransferase inhibitor | |||
| 0.032 | 0.03 | 0.032 | Nicotinic acid receptor agonist | |||
| 0.018 | 0.017 | 0.018 | Caspase 8 inhibitor | |||
| 0.01 | 0.009 | 0.01 | Beta 3 adrenoreceptor agonist | |||
| 0.047 | 0.046 | 0.047 | Glucose-6-phosphate translocase inhibitor | |||
| 0.039 | 0.044 | 0.056 | Microtubule stabilization | 0.056 0.02 CID_124202069 | CID_124202069 | |
| 0.059 | 0.071 | 0.072 | Histone deacetylase SIRT1 stimulant | 0.072 0.053 CID_124202069 | CID_124202069 | |
| 0.059 | 0.071 | 0.072 | Histone deacetylase stimulant | 0.072 0.053 CID_124202069 | CID_124202069 | |
| 0.004 | 0.028 | 0.013 | Antibiotic Macrolide-like | 0.013 0.011 CID_124202069 | CID_124202069 | |
| 0.088 | 0.115 | 0.193 | Cyclooxygenase 1 inhibitor | 0.193 0.037 CID_124202069 | CID_124202069 | |
| 0.07 | 0.102 | 0.159 | Topoisomerase I inhibitor | 0.159 0.038 CID_124202069 | CID_124202069 | |
| 0.026 | 0.059 | 0.064 | Antibiotic Aminoglycoside-like | 0.064 0.007 CID_124202069 | CID_124202069 | |
| 0.009 | 0.055 | 0.02 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.02 0.014 CID_124202069 | CID_124202069 | |
| 0.007 | 0.082 | 0.297 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.297 0.002 CID_124202069 | CID_124202069 | |
| 0.011 | 0.103 | 0.044 | Protein 30S ribosomal subunit inhibitor | 0.044 0.009 CID_124202069 | CID_124202069 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |